8KDG
Structure of LAT1-CD98hc-Fab170 in complex with BCH, consensus map
Summary for 8KDG
Entry DOI | 10.2210/pdb8kdg/pdb |
EMDB information | 37135 |
Descriptor | 4F2 cell-surface antigen heavy chain, Large neutral amino acids transporter small subunit 1, Fab170 light chain, ... (6 entities in total) |
Functional Keywords | transporter, amino acid, complex, cancer, transport protein |
Biological source | Homo sapiens (human) More |
Total number of polymer chains | 4 |
Total formula weight | 174491.29 |
Authors | |
Primary citation | Lee, Y.,Jin, C.,Ohgaki, R.,Xu, M.,Ogasawara, S.,Warshamanage, R.,Yamashita, K.,Murshudov, G.,Nureki, O.,Murata, T.,Kanai, Y. Structural basis of anticancer drug recognition and amino acid transport by LAT1. Nat Commun, 16:1635-1635, 2025 Cited by PubMed Abstract: LAT1 (SLC7A5) transports large neutral amino acids and plays pivotal roles in cancer proliferation, immune response and drug delivery. Despite recent advances in structural understanding of LAT1, how it discriminates substrates and inhibitors including the clinically relevant drugs remains elusive. Here we report six structures of LAT1 across three conformations with bound ligands, elucidating its substrate transport and inhibitory mechanisms. JPH203 (also known as nanvuranlat or KYT-0353), an anticancer drug in clinical trials, traps LAT1 in an outward-facing state with a U-shaped conformer, with its amino-phenylbenzoxazol moiety pushing against transmembrane helix 3 (TM3) and bending TM10. Physiological substrates like ʟ-Phe lack such effects, whereas melphalan poses steric hindrance, explaining its inhibitory activity. The "classical" system L inhibitor BCH induces an occluded state critical for transport, confirming its substrate-like behavior. These findings provide a structural basis for substrate recognition and inhibition of LAT1, guiding future drug design. PubMed: 39952931DOI: 10.1038/s41467-025-56903-w PDB entries with the same primary citation |
Experimental method | ELECTRON MICROSCOPY (3.68 Å) |
Structure validation
Download full validation report
